Plasma proteomic analyses and treatment predictive biomarker candidates in melanoma patients receiving immune checkpoint blockade or targeted therapy.

JSON

Eriksson H, Babacic H, Lehtio J, Pernemalm M

J Clin Oncol 37 (15_suppl) 9574-9574 [2019-05-20; online 2019-05-20]

DOI 10.1200/jco.2019.37.15_suppl.9574

Crossref 10.1200/jco.2019.37.15_suppl.9574